


unitma
Medical Equipment Manufacturing • 3F. Chungmyeong BD, 224-8, Korea, Republic of • 1-10 Employees
Company overview
| Headquarters | 3F. Chungmyeong BD, 224-8, Jamsil-Dong, Songpa-Ku,, Seoul,, KR |
| Website | |
| SIC | 873 |
| Keywords | Diabetes, Insulin Pump, Pathological Research, Tissue Microarray Technology |
| Founded | 2004 |
| Employees | 1-10 |
| Socials |
Key Contact at unitma
Youngdo Lee
Marketing Director
About unitma
UNITMA is a leading provider of products and services that improve productivity in clinical, analytical and research laboratories. Tissue Microarray technology from UNITMA is a powerful tool that can be applied to most of the know-how about tissues for immunohistochemistry, in situ hybridization, FISH and in situ PCR. Also Unitma is the exclusive global distributor of insulin pump, Willcare (GX-1020)
unitma revenue & valuation
| Annual revenue | $12,500,000 |
| Revenue per employee | $4,167,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $40,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
unitma has never raised funding before.
unitma Tech Stack
Discover the technologies and tools that power unitma's digital infrastructure, from frameworks to analytics platforms.
Web servers
Operating systems
Frequently asked questions
4.8
40,000 users



